Results 191 to 200 of about 428,568 (350)
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić +4 more
wiley +1 more source
The First Cleaner Ant? A Novel Partnership in the Arizona Desert. [PDF]
Moffett MW.
europepmc +1 more source
Aims To determine the prevalence of non‐adherence to antihypertensive medicines and to identify demographic and behavioral factors associated with non‐adherence in subjects enrolled in the May Measurement Month (MMM) 2023, as part of the permanent public health action Hunting the silent killer.
Valerija Bralić Lang +12 more
wiley +1 more source
A Baton for Karaoke Intertwined with The Blade of The Surgeon. [PDF]
Hong JP, Innocenti M, Hallock GG.
europepmc +1 more source
Portrait of Reverend Joseph Vasilon, Greek-Orthodox priest
University of Colorado Boulder
openalex +1 more source
Introduction In recent years, the treatment of spinal muscular atrophy (SMA), a rare disease, has significantly progressed, improving patients' survival and overall quality of life. However, current SMA treatments are expensive, and some (nusinersen) are very inconvenient for patients.
Andrej Belančić +4 more
wiley +1 more source
Uniqueness of Gauge Covariant Renormalisation of Stochastic 3D Yang-Mills-Higgs. [PDF]
Chevyrev I, Shen H.
europepmc +1 more source

